Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter VI Diseases of the nervous system,G6_NEURODEGENERATIVE,APOE,Apolipoprotein E,Inverse variance weighted,14,0.26 [0.2-0.33],1.94897299482755e-29,cis
Chapter VI Diseases of the nervous system,G6_NEURODEGENERATIVE,NPTXR,Neuronal pentraxin receptor,Inverse variance weighted,4,0.66 [0.51-0.86],0.00238063290464186,cis
Chapter VI Diseases of the nervous system,G6_NEURODEGENERATIVE,MENT,Protein MENT,Wald ratio,1,4.29 [1.14-16.08],0.0309305165459145,cis
Chapter VI Diseases of the nervous system,G6_NEURODEGENERATIVE,APOA2,Apolipoprotein A-II,Wald ratio,1,0.38 [0.15-0.92],0.0323567153521552,cis
Chapter VI Diseases of the nervous system,G6_NEURODEGENERATIVE,VGF,Neurosecretory protein VGF,Wald ratio,1,2.42 [0.68-8.65],0.174667627157461,cis
Chapter VI Diseases of the nervous system,G6_NEURODEGENERATIVE,GFAP,Glial fibrillary acidic protein,Inverse variance weighted,4,1.32 [0.85-2.05],0.224285164426187,cis
Chapter VI Diseases of the nervous system,G6_NEURODEGENERATIVE,SNAP25,Synaptosomal-associated protein 25,Wald ratio,1,0.64 [0.2-2.09],0.46172526533404,cis
Chapter VI Diseases of the nervous system,G6_NEURODEGENERATIVE,GDF15,Growth/differentiation factor 15,Inverse variance weighted,10,1.03 [0.85-1.25],0.771562417778492,cis
